Form 4 for ISRG Intuitive Surgical
Accepted 2024-07-31 00:00:00 ET · period of report 2024-07-30 · accession 0001035267-24-000219 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DI | 2024-07-31 | 2024-07-30 | ISRG | GUTHART GARY S | CEO, Dir | G - Gift | $0.00 | -12.5K | 1.19M | -1% | $0 |
| D | 2024-07-31 | 2024-07-30 | ISRG | GUTHART GARY S | CEO, Dir | M - OptEx | $57.11 | +25.2K | 40.6K | +164% | +$1.44M |
| D | 2024-07-31 | 2024-07-30 | ISRG | GUTHART GARY S | CEO, Dir | S - Sale+OE | $443.07 | -23.4K | 17.2K | -58% | -$10.36M |
| DMI | 2024-07-31 | 2024-07-30 | ISRG | GUTHART GARY S | CEO, Dir | S - Sale+OE | $445.09 | -7,440 | 23.6K | -24% | -$3.31M |
| D | 2024-07-31 | 2024-07-30 | ISRG | GUTHART GARY S | CEO, Dir | M - OptEx | $0.00 | -25.2K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-30 | G | D | 12,500 | $0.00 | 1,191,144 | I by Trust FBO Son | — | — | |
| 2 | Common | Common Stock | 2024-07-30 | M | A | 25,200 | $57.11 | 40,558 | D by Trust | — | — | |
| 3 | Common | Common Stock | 2024-07-30 | S | D | 23,388 | $443.07 | 17,170 | D by Trust FBO Daughte | — | — | (F2) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $437.94 to $447.76 as follows: 1,797 shares sold at $437.94 to $438.93; 1,345 shares sold at $439.00 to $440.00; 3,108 shares sold at $440.11 to $441.10; 5,000 shares sold at $442.35 to $443.29; 5,182 shares sold at $443.38 to $444.36; 4,556 shares sold at $444.39 to $445.25; 800 shares sold at $445.62 to $445.80; and 1,600 shares sold at $447.00 to $447.76. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 4 | Common | Common Stock | 2024-07-30 | S | D | 3,720 | $445.12 | 23,640 | I | — | — | (F5) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $443.66 to $447.85 as follows: 1,552 shares sold at $443.66 to $444.62; 1,400 shares sold at $444.84.00 to $445.29; 568 shares sold at $446.46 to $447.33; and 200 shares sold at $447.76 to $447.85. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 5 | Common | Common Stock | 2024-07-30 | S | D | 3,720 | $445.07 | 23,640 | I | — | — | (F4) The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $443.66 to $447.85 as follows: 1,465 shares sold at $443.66 to $444.31; 1,601 shares sold at $444.93 to $445.80; 554 shares sold at $446.46 to $447.08; and 100 shares sold at $447.85. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
| 6 | Derivative | Non-Qualified Stock Option (right to buy) | 2024-07-30 | M | D | 25,200 | $0.00 | 0 | D | $57.11 · — to 2025-02-17 | 25,200 Common Stock | (F6) Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter. |